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Abstract
Introduction:  Wine is worldwide known drink with a long history. It is popular in many
cultures and diets. It is a component of Mediterranean diet, which is an example of healthy
eating. Red wine seems to be an essential component of the diet, since moderate consumption
of wine is associated with lower risk and mortality from cardiovascular disease.
The aim of  the  study:  The  purpose  of  this  systemic  review was  to  collect  and analyse
available data about health properties of wine.
Material and method: Standard criteria were used to review the literature data. The search of
articles in the PubMed database was carried out using the following keywords: wine, alcohol,
cardiovascular, polyphenols.
Description of the state of knowledge: Pro-health properties of alcohol depends mainly on
the  content  of  polyphenols.  The  most  biologically  active  polyphenol  is  resveratrol.  Light
drinking of wine has multiple beneficial effects. It decreases level of  total plasma cholesterol,
low-density  lipoprotein  and  increases  high-density  lipoprotein,  lowers  blood  fibrinogen,
thromboxane  A,  platelet  stickiness,  reducing  insulin  resistance,  inhibits  inflammation,
improves  endothelial  function,  fibrinolysis  and  increases  plasma  concentration  of  atrial
natriuretic peptide. In addition it may have neuroprotective effect and beneficial effect on gut
microbiota.
Summary: Moderate wine consumption can be beneficial for our health, may protect against
cardiovascular disease, atherosclerosis, hypertension, certain types of cancer, type 2 diabetes,
neurological  disorders  and  metabolic  syndrome.  Nevertheless,  any  amount  of  alcohol
consumed can lead to alcohol addiction and there is a very thin line between drinking small
amounts and abuse. Furthermore, there are studies indicating that small amounts of alcohol
can also have a negative impact on health. This subject still needs more studies and clinical
trials.
Keywords: wine, polyphenols, alcohol
1. Introduction
Red wine is a worldwide known drink with a long history since it was popular even in
ancient times [1]. Wine can be found in many cultures, but especially in Mediterranean diet
[2].  Low to  moderate  red  wine  consumption  can  be  beneficial  for  our  health  since  it  is
associated  with  lower  mortality  from  cardiovascular  and  cerebrovascular  disease  [3].
However, it is very important to emphasize that it only applies to light drinking. It is well
known that alcohol can have many negative and serious health effects. Harmful use of alcohol
is  responsible  for  5.9%  of  all  deaths,  and  5.1%  of  the  global  burden  of  disease [4].
Nevertheless, the French paradox exists and is associated with a daily glass of wine [5]. Red
wine seems to have some positive effects, so the aim of this article is to discuss how it can
influence our health.
2. Polyphenols
Red wine  is  known as  a  source  of  phenolics  since  it  contains  10-fold  more  phenolic
compounds than white wine [6]. For white wines the concentration of polyphenol content is
around  50-400  mg/L,  while  for  red  wines  it  is  900-1400  mg/L.  The  differences  in
concentration  appear  due  to  differences  in  enological  practices  and  regarding  grape  like
variety,  soil  and  climate.  Red  wine  phenolics  can  be  divided  into  two  major  groups:
flavonoids  (flavan 3 ols,  the  flavonols,  and  the  anthocyanins)  and  non-flavonoids‐ ‐
(hydroxycinnamates, hydroxybenzoates and the stilbenes) [7,8]. The benefits of red wine are
studied since the discovery of the French paradox [9], which is low rates of coronary heart
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disease and low risk of cardiac mortality in the French populace despite of high intakes of
dietary  cholesterol  and saturated  fat  [10].  These  phenolics  reduce  low-density  lipoprotein
(LDL) cholesterol oxidation and reduce platelet aggregation which contribute to lower risk of
coronary diseases [11]. Both long-term abuse of alcohol and binge drinking are associated
with atrial fibrillation. However, this relationship is not that certain with light and moderate
drinking  [9].  Studies  show  that  light-to-moderate  alcohol  consumers  have  an  increased
survival compared to abstainers [11]. All the benefits are associated with flavonoids that are
polyphenolic compounds. It is commonly known that high intake of fruits and vegetables is
beneficial  for our health [12,13].One of the reasons is high content of flavonoids in these
foods [13].
Flavonols  are  a  diverse  family  of  monomeric  (catechin,  epicatechin),  oligomeric  and
polymeric  (proanthocyanidins,  also  called  condensed  tannins)  chemical  compounds.  The
astringency, bitterness, and structure of wines depend on catechin and epicatechin which can
be found in skin and seeds of grape [6]. Anthocyanins are pigments found in plants, flowers
and fruits [7]. Tannins may be divided into two groups: hydrolysable tannins and condensed
tannins  (also  named catechin  tannins  or  proanthocyanidins)  [14].  Many studies  show the
beneficial effects on health of tannins mostly due to its antioxidant properties and, thus, could
help in the prevention of inflammation disorders, cardiovascular diseases, or have protective
effects to lower the risk of various cancers [14,15]. Another compound is resveratrol that is
responsible for multiple biological effects. However, the way of action of resveratrol is not
fully known yet [16]. The variety of molecular targets of resveratrol seems to be the key of its
mechanism  of  action  [16,17].  Studies  showed  that  resveratrol  has  beneficial  effect  on
cardiovascular  system  [18,19,20],  cancer  treatment  [21,22],  has  antioxidant  and
immunomodulatory effects for some autoimmune diseases [23], anti-diabetic effects [24] and
neuroprotective activity [25].
3. Wine and cardiovascular health
Drinking  wine  definitely  has  an  impact  on  functioning  of  the  cardiovascular  system.
Moderate  wine intake reduces cardiovascular  risk [26]. It decreases level of  total  plasma
cholesterol, low-density lipoprotein (LDL) and increases high-density lipoprotein [11]. It also
causes less LDL oxidation, which in vessel wall promotes atherosclerosis [27]. In addition to
the positive effects on cholesterol, the wine has many other positive effects. It lowers blood
fibrinogen,  thromboxane  A,  platelet  stickiness.  This  effects  decrease  clot  formation  in
atherosclerotic blood vessels [27]. It lowers the risk of type 2 diabetes mellitus, probably by
reducing insulin resistance, inhibits inflammation, improves endothelial function, fibrinolysis
and increases  plasma concentration  of  atrial  natriuretic  peptide  [28,29,30].  Wine contains
resveratrol(3,5,4' trihydroxy trans stilbene)  –  one  of  the  most  biologically  active‐ ‐ ‐
polyphenols [26].It lowers production of reactive oxygen species (ROS) , because it  inhibits
NADPH-oxidase by down-regulating its expression and activity [31]. ROS cause oxidative
stress  and  contribute  do  development  of  cardiovascular  disease,  such  as  ischemic  heart
disease, hypertension, cardiac hypertrophy, atherosclerosisand congestive heart failure [26].
Literature reports that resveratrol may have anti-arrhythmic effects and may act as inhibitor of
both intracellular calcium release and pathological signaling cascades in atrial fibrillation [9].
There  are  several  preclinical  studies  on  animal  models  that  show  protective  effect  of
resveratrol on cardiovascular disease, such as hypertension, hypercholesterolemia, ischaemic
heart  disease,  diabetes  and atherosclerosis  [32,33,34,35,36].  Moderate  wine  drinking  may
decrease psychological stress, which is a possible coronary artery disease risk factor. All of
these effects are related to “light” drinking, which is defining as less than 3 standard drinks
per  day,  heavy  drinking(≥ 3  standard  drinks  per  day)can  be  catastrophic  in  terms  of
cardiovascular health [27]. On the other hand alcohol abuse has undoubtedly negative effects
including alcohol dependence syndrome, liver cirrhosis, alcoholic cardiomyopathy, systemic
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hypertension,  hemorrhagic  stroke,  heart  rhythm  disturbances,  encephalopathies,
polyneuropathy, dementia [27,37].
The epidemiological data indicate that light drinking has a beneficial effect on health
[4]. One meta-analysis shows that drinking wine has a protective effect against cardiovascular
risk  and  reduces  total  mortality,  which  is  probably  associated  with  the  presence  of  high
concentrations of polyphenols in wine. We do not observe this effects in drinking spirits, due
to the lowest polyphenolic concentration [26,38]. Two studies show that low and moderate
wine drinking, decrease mortality of coronary artery disease [39,40]. Nevertheless, one study
of 32 826 women enrolled in the Nurses Health Study followed up from 1990 to 1998 and 18
225 men enrolled in the Health Professionals Follow-Up Study followed up from 1994 to
2000 and second prospective study among 85,709 women, 34 to 59 years of age show no
differences in health benefits between moderate drinking of any types of drink [41,42].
4. Wine and cancer prevention
Ethanol  is  classified  by  International  Agency  for  Research  on  Cancer  (IARC)  as
carcinogenic to humans. Its carcinogenic effect depends on the amount of alcohol consumed
and  increases  with  increasing  consumption  of  ethanol.  Epidemiological  data  are  hard  to
analyze due to the presence of other risk factors for cancer such as smoking, diet,  family
history or hormone-replacement therapy [11].Available data is still inconclusive in terms of
low alcohol intake and reduced risk of cancer.  There is evidence that wince consumption
decreases the risk of cancer of upper digestive tract, lung, colon, basal cell carcinoma, non-
Hodgkin  lymphoma  and  prostate  [43,44].   The  protective  effect  of  moderate  wine
consumption on cancer may be mainly attributed to polyphenols [43]. As with cardiovascular
disease, resveratrol seems to have the greatest importance. Studies show that “light” drinking
of wine may reduce the  risk of developing lung cancer [45]. A study on female with non-
Hodgkin's lymphoma showed that moderate wine intake increased 5-year survival to 75%
from 69% in abstainers [46]. However, excessive alcohol consumption increases the risk of
death of people with non-Hodgkin lymphoma compared to abstainers [47]. Drinking about 1
glass of  wine per  day decreases  the risk of developing Barrett’s  esophagus,  compared to
heavy-drinkers and abstainers [48].There are several mechanisms in which resveratrol inhibits
promotion  and  progression  of  the  cancer  process.  This  mechanisms  are  inhibition  of
cytochrome  P450  enzymes,  antioxidant,  anti-inflammatory  activities,  and  effects  on  cell
cycle,  cellproliferation  and  apoptosis  [43].  Anti-tumor  initiation  activity  of  resveratrol  is
based on its antioxidant properties.  Oxidative stress plays a dominant part in the causation of
carcinogenesis [21]. Studies conducted in vitro have discovered that resveratrol exerts an anti-
proliferative  activity  by  inducing  apoptosis  [49].  It  also  modulates  signal  transduction,
immune  response,  transcription  factors,  growth  factors,  cytokines,  caspases,  interleukins,
prostaglandin synthesis and cell cycle-regulating proteins [11].Experimental studies show its
anticarcinogenic properties [50]. It should be remembered that moderate drinking of alcohol
has many disadvantages. There are reports that even light or moderate alcohol consumption
can  contribute  to  development  of  breast  cancer,  which  is  caused  by  increased  levels  of
estrogen and the production of reactive oxygen species during alcohol metabolism [51,52].
Another study also shows that alcohol consumption increases the risk of breast cancer in post-
menopausal women [53]. 
5. Wine and diabetes mellitus type 2
Type 2-diabetes mellitus is affected mainly by lifestyle. The aim of therapy for diabetes is
to keep the blood glucose level at optimum level. One of the therapeutic goals is inhibition of
α-glucosidase [7]. Several studies show that red wine contains compounds that show strong
inhibitory effect on α-glucosidase and  α-amylase. α-glucosidase catalyzes the disaccharides
distribution and  α-amylase breaks down long-chain carbohydrates [54]. These effects  may
contribute to better control of postprandial glycemia.  Wine flavonoids also inhibit  glucose
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absorption in the intestine by sodium-dependent glucose transporter 1 (SGLT1). It stimulates
insulin secretion and reduces hepatic glucose output [7].Flavonoids can also activate  AMP-
activated  protein  kinase  (AMPK).  AMPK  activation  modulates  glucose  and  fatty  acid
metabolism, mitochondrial function, endoplasmic reticulum stress, autophagy, and apoptosis.
In study on type 2 diabetic mice the AMPK activation was often accompanied by the up-
regulation of glucose transporter 4 (GLUT4) in skeletal muscle and the down-regulation of
gluconeogenesis  in  the  liver.  This  mechanism  improves insulin  sensitivity  in  the  skeletal
muscle and liver [55,56]. 
6. Neuroprotection
Neurodegenerative diseases, like Alzheimer's disease or Parkinson's disease, are mostly
age-dependent  disorders [57].  It  is  believed that  onset of those diseases  and subsequently
neuronal death appears before first symptoms can be noticed. That means we do not know
when was the beginning of the disease nor how late the treatment started.  Moreover, there is
not enough information about how to prevent neurodegenerative diseases [58]. A study of
Parkinson's disease showed that intake of dietary antioxidants was associated with a lower
risk of Parkinson's disease [59]. A concept of wine-related compounds having neuroprotective
and neurorescue effects starts to be accepted. Not only because of antioxidant activities of
those  compounds,  but  also  via  suppressing  neuroinflammation,  modulating  signalling
pathways,  decreasing  mitochondrial  dysfunction  and  anti-aggregating  properties  [60].
Resveratrol shows antioxidant and anti-inflammatory effects, but the problematic issue is poor
absorption of resveratrol [61]. Another study also indicates resveratrol as a potetnial substance
in  Alzheimer's  disease  treatment  due  to  its  multiple  mechanisms  in  neuroprotection  [62].
Wine polyphenols  seems to be potentially  neuroprotective  agents,  however,  more  clinical
trials on this subject are needed [63].
7. Microbiota
Microbiota is as name for microorganisms that can be found on a given habitat. Large
intestine  is  a  place  where  bacterial  density  reach  1011–1012 bacteria  per  gram  [64].  The
composition of gut microbiota is changing throughout life especially during development and
diet is one of the influencing factors [65]. The bioavailability of polyphenols is very low, so
the vast majority of them persist into the colon [66,67]. Polyphenols may be considered as a
potential  substance  in  preventing  or  treating  inflammatory  gut  disorders  due  to  their
antioxidant  properties  [68].  Polyphenols  after  intestinal  transformations,  firstly  because of
digestive  enzymes  and  then  due  to  the  action  of  microbiota,  may  show strong  antiviral,
antibacterial, and antiparasitic activities [69]. However, these effects are not the only benefits
of polyphenols, since there is a new concept of polyphenols as potential prebiotic candidates
[66]. The meaning of the word ‘probiotic’ is ‘for live’ in greek, but  another, more specific
definition is that it is “a nondigestible food ingredient that beneficially affects the host by
selectively stimulating the growth and/or activity of one or a limited number of bacteria in the
colon” [70]. Studies showed that two of the wine phenolic compounds are able to promote the
growth of beneficial bacteria and the inhibition of pathogenic bacteria [71]. One of the studies
which was a randomized, crossover, and controlled trial compared changes in micobiota of
the participants who were asked to drink red wine, de-alcoholised red wine and gin for a
specific period of time. Study showed significant changes in the fecal microbiota of all the
participants depending on the kind of beverage consumed [72]. An increase of  Bacteroides
and  Clostridium frequencies  and a disappearance of  Prevotellaceae  were noticed after the
period  of  ethanol  (gin)  consumption.  The  other  thing  is  that  the  diversity  of  the  fecal
microbiota was higher after  the red wine period. Phenolic compounds of red wine caused
increase  in  the  concentration  of  Firmicutes and  Bacteroidetes,  Enterococcus,
Prevotella,Bifidobacterium,  Bacteroidesuniformis,  Eggerthellalenta,  and  Blautiacoccoides–
Eubacterium rectal.  At  the same time,  there were no significant  changes  in  Lactobacillus
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species concentration. These results showed that small ethanol doses plus polyphenol intake
for  a  short  time  can  modulate  the  composition  of  gut  microbiota  [72].  Another  study
indicating that flavanols are able to influence the growth of specific large-intestinal bacteria
showed this ability of  monomers catechin and epicatechin. Both of them, but in particular
catechin is responsible of the growth of  C. coccoides–Eubacterium recital, which is a group
of bacteria  linked to  the positive  effects  at  the cellular  and systemic  level.  Moreover,  an
increase of bifidobacteria was also noticed after catechin exposure, and this bacterial group
present  an  ability  to  inhibit  the  growth  of  pathogenic  micro-organisms  [73].  It  has  been
suggested the consumption of red wine increased the diversity of microbiota [74].
8. Summary
All the protective effects  on cardiovascular  system,  cancer prevention,  type 2-diabetes
mellitus,  neuroprotection  and  microbiota  composition  that  seem  to  come  from  red  wine
consumption are associated with the phenols contained in it. That means that moderate wine
consumption  that  is  a  part  of  Mediterranean  diet  can  be  beneficial  for  our  health.
Nevertheless, any amount of alcohol consumed can lead to alcohol addiction and there is a
very thin line  between drinking small  amounts  and abuse.  Furthermore,  there  are  studies
indicating  that  small  amounts  of alcohol  can also have a  negative impact  on health.  This
subject still needs more studies and clinical trials.
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74. Barroso E, Muñoz González I, Jiménez E, Bartolome B, Moreno Arribas MV, Pelaez‐ ‐
C, et al. Phylogenetic profile of gut microbiota in healthy adults after moderate intake
of red wine. Molecular nutrition & food research. 201761(3):1600620.
208
